BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12713596)

  • 21. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
    López-Parra M; Clària J; Planagumà A; Titos E; Masferrer JL; Woerner BM; Koki AT; Jiménez W; Altuna R; Arroyo V; Rivera F; Rodés J
    Br J Pharmacol; 2002 Feb; 135(4):891-900. PubMed ID: 11861316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice.
    Peebles RS; Hashimoto K; Morrow JD; Dworski R; Collins RD; Hashimoto Y; Christman JW; Kang KH; Jarzecka K; Furlong J; Mitchell DB; Talati M; Graham BS; Sheller JR
    Am J Respir Crit Care Med; 2002 Apr; 165(8):1154-60. PubMed ID: 11956061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development.
    Kömhoff M; Wang JL; Cheng HF; Langenbach R; McKanna JA; Harris RC; Breyer MD
    Kidney Int; 2000 Feb; 57(2):414-22. PubMed ID: 10652018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching.
    Sugimoto M; Arai I; Futaki N; Honma Y; Sakurai T; Hashimoto Y; Nakaike S
    Prostaglandins Leukot Essent Fatty Acids; 2007 Feb; 76(2):93-101. PubMed ID: 17250998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.
    Drachman DB; Frank K; Dykes-Hoberg M; Teismann P; Almer G; Przedborski S; Rothstein JD
    Ann Neurol; 2002 Dec; 52(6):771-8. PubMed ID: 12447931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta.
    Morgan MP; Whelan LC; Sallis JD; McCarthy CJ; Fitzgerald DJ; McCarthy GM
    Arthritis Rheum; 2004 May; 50(5):1642-9. PubMed ID: 15146435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2.
    Koetzner L; Hua XY; Lai J; Porreca F; Yaksh T
    J Neurosci; 2004 Feb; 24(6):1451-8. PubMed ID: 14960618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory modulation and wound repair.
    Davidson JM; Breyer MD
    J Invest Dermatol; 2003 May; 120(5):xi-xii. PubMed ID: 12713603
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain.
    Zhang YH; Lu J; Elmquist JK; Saper CB
    J Comp Neurol; 2003 Aug; 463(1):3-12. PubMed ID: 12811798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
    Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
    Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intravenous administration of FR122047 (a selective cyclooxygenase 1 inhibitor) and FR188582 (a selective cyclooxygenase 2 inhibitor) on prostaglandin-E2-induced aqueous flare elevation in pigmented rabbits.
    Abe T; Hayasaka Y; Zhang XY; Hayasaka S
    Ophthalmic Res; 2004; 36(6):321-6. PubMed ID: 15627832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.